Si Li

Si Li

Auto-generated profile, based on publicly available information

Si Li

College of Animal Science and Technology, Hunan Agricultural University, Changsha, Hunan 410128, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SLSi Li
Si Li
CFChenxing Fu
Chenxing Fu
YZYurong Zhao
Yurong Zhao
JHJianhua He
Jianhua He
The intestinal microbiome plays a crucial role in promoting intestinal health, and perturbations to its constitution may result in chronic intestinal inflammation and lead to colorectal cancer (CRC).α-Ketoglutarate is an important intermediary in the NF-κB-mediated inflammatory pathway that maintains intestinal homeostasis and prevents initiation of intestinal inflammation, a known precursor to carcinoma development. The objective of this study was to assess the potential protective effects ofα-ketoglutarate intervention against CRC development, which may arise due to its known anti-inflammatory and antitumour effects. CRC was induced in C57BL/6 mice using azoxymethane (AOM) and dextran sulfate sodium (DSS). Tumour frequency, histological rating, and colonic microbiota were assessed in colonic samples. The findings demonstrated thatα-ketoglutarate offered significant protection against CRC development in mice. Furthermore,α-ketoglutarate also exhibited immunomodulatory effects mediated via downregulation of interleukin (IL)-6, IL-22, tumour necrosis factor (TNF)-α, and IL-1βcytokines. Finally, intervention withα-ketoglutarate tended to minimise the frequency of opportunistic pathogens (EscherichiaandEnterococcus) while increasing the populations ofAkkermansia, Butyricicoccus,Clostridium,andRuminococcus. Taken together, our findings show that dietaryα-ketoglutarate intervention may protect against inflammation-related CRC.